·¬ΗΡΙηΗψapp

Oncology/Hematology

Ovarian Cancer

More in Ovarian Cancer

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

News, features, and commentary about cancer-related issues

Jun 13, 2024
Onco Break over a computer rendering of a cancer cell.
'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trial

News, features, and commentary about cancer-related issues

Jun 06, 2024
Onco Break over a computer rendering of a cancer cell.
Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers

Clear cell histology "is what yields the super response we see in these trials," expert suggests

Jun 04, 2024
ASCO over a photo of McCormick Place in Chicago, IL
Lymphadenectomy Not Needed in Advanced Ovarian Cancer With Optimal Surgery

PFS was not significantly different for those who skipped lymphadenectomy

Jun 03, 2024
ASCO over a photo of McCormick Place in Chicago, IL
Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?

News, features, and commentary about cancer-related issues

May 31, 2024
Onco Break over a computer rendering of a cancer cell.
Estrogen-Only Therapy for Menopausal Symptoms Increases Ovarian Cancer Risk

Incidence, mortality double over 20 years, while estrogen plus MPA lowers endometrial cancer risk

May 24, 2024
ASCO over a photo of McCormick Place, in Chicago, IL
Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound?

News, features, and commentary about cancer-related issues

May 17, 2024
Onco Break over a computer rendering of a cancer cell.
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests

News, features, and commentary about cancer-related issues

Apr 19, 2024
Onco Break over a computer rendering of a cancer cell.
Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol?

News, features, and commentary about cancer-related issues

Apr 12, 2024
Onco Break over a computer rendering of a cancer cell.
Novel PARP1 Inhibitor Shows Promise in Breast Cancer

The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study

Apr 09, 2024
AACR over a photo of San Diego Convention Center in San Diego, CA
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials?

Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all

Apr 08, 2024
AACR over a photo of San Diego Convention Center in San Diego, CA
Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers

About half of patients responded, duration of response as long as 19 months in three trials

Apr 05, 2024
FDA APPROVED trastuzumab deruxtecan (Enhertu) over a computer rendering of antibodies attacking cancer cells
Cancer 'Tidal Wave' Forecast; Not Decaf, Too! Cautionary Tales of Cancer, Cannabis

News, features, and commentary about cancer-related issues

Apr 05, 2024
Onco Break over a computer rendering of a cancer cell.
Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations

News, features, and commentary about cancer-related issues

Mar 29, 2024
Onco Break over a computer rendering of a cancer cell.
More in Ovarian Cancer